🇺🇸 FDA
Patent

US 7056954

Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

granted A61KA61K31/203

Quick answer

US patent 7056954 (Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/203